Aisling Capital
New York City, New Yorkaislingcapital.com
Overview
Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies . Aisling Capital seeks to identify differentiated healthcare products, services and technologies that address unmet medical needs .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Treeline Biosciences | Sep 2025 | Series A Extension | Co-investor |
| Wugen | Aug 2025 | Early Funding | Co-investor |
| A2 Biotherapeutics | Jan 2025 | Series C | Co-investor |
| GondolaBio | Aug 2024 | VC Round | Co-investor |
| BridgeBio Oncology | May 2024 | VC Round | Co-investor |
Key People
Dennis Purcell
Founder And Senior Advisor
Aftab Kherani
Operating Partner
Scott Braunstein
Operating Partner
Eric Aguiar
Partner
Kevin Yeo
Partner
Sunny Reddy
Principal
Wonpyo Yun
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.